Financial Data and Key Metrics Changes - Fiscal second quarter revenue decreased by 1% to $484 million in 2025 from $488 million in 2024 [14] - New boat sales were down 5% to $310 million, while pre-owned boat sales increased by 14% to $90 million [14] - Gross profit declined to $110 million in 2025 compared to $120 million in 2024, driven by lower gross margins [15] - Net loss for the fiscal second quarter totaled $375,000 or $0.02 per diluted share, compared to a net loss of $5 million or $0.27 per diluted share in the prior year [16] - Adjusted income per diluted share was $0.13 compared to $0.67 in the prior year [17] Business Line Data and Key Metrics Changes - Same store sales declined by 2%, primarily due to a decrease in new boat sales [4] - Revenue from service parts and other sales increased by 2% to $69 million, driven by growth in the dealership segment [14] - Parts and service business revenue was up 2%, partially offset by headwinds in the distribution segment [12] Market Data and Key Metrics Changes - Total unit sales for the industry were down in excess of 10% for the quarter, while the company continued to outperform the industry and gain market share [4] - The average unit price of new boats increased, driven by continued strength in larger boats [11] - Financing and insurance revenue increased slightly as a percentage of total sales, indicating strong performance in in-store financing programs [12] Company Strategy and Development Direction - The company is focused on inventory and brand rationalization strategies, reducing inventory by 12% year over year [5] - The company plans to exit 15 brands to streamline operations and focus on higher-performing brands [46][48] - The company is monitoring the tariff landscape closely and does not expect an immediate impact on pricing for current inventory [8] Management's Comments on Operating Environment and Future Outlook - Management expressed cautious optimism about demand in April, indicating that results were in line with the prior year [22] - The macroeconomic environment remains uncertain, leading to an updated fiscal 2025 guidance with total sales expected to be in the range of $1.7 billion to $1.8 billion [20] - Management emphasized the importance of controlling factors within their operations to navigate current challenges [9] Other Important Information - Total liquidity as of March 31, 2025, was in excess of $74 million [18] - Total inventory decreased to $602 million from $687 million year over year, indicating a healthier mix and aging profile [18] - The company aims to reduce leverage in the latter half of 2025 as part of its capital allocation strategy [19] Q&A Session Summary Question: What is the demand outlook post-tariff announcements? - Management indicated that April results were in line with the previous year, with positive signs for May [22][23] Question: What drove the margin down on used boats? - Management noted that the model mix and aggressive pricing strategies to move inventory contributed to the softer margins [25][26] Question: Where is the company gaining market share? - The majority of market share gains are in the premium segment, with the company performing better than the industry average [32][33] Question: Is the company discounting heavily to gain share? - Management confirmed that while some discounting is occurring, it is strategic and focused on moving dated inventory [36][37] Question: How does the company see the industry evolving post-slowdown? - Management anticipates potential consolidation in the industry due to higher carrying costs and competitive pressures [41][45]

Financial Performance - First quarter sales increased by 2% year-over-year, from $800.5 million to $814.3 million[18, 80] - Organic sales decreased by 1%[19] - Adjusted EBITDA margin decreased by 50 bps, from 26% to 25.5%[18] - Adjusted EPS decreased by 7%, from $1.88 to $1.75[18] - Free cash flow decreased by 33%, from $136.6 million to $91.4 million[18, 82] Segment Results - Health & Science Technologies (HST) sales increased by 10%, with organic sales down by 1%[27] - Fluid & Metering Technologies (FMT) sales decreased by 7%, with organic sales down by 4%[33] - Fire & Safety/Diversified Products (FSDP) sales increased by 4%, with organic sales up by 5%[42] Guidance - The company expects organic revenue to increase by 1% to 3% for the full year 2025[49] - The company expects adjusted EBITDA to be 27.5% to 28.0% for the full year 2025[49] - The company expects adjusted EPS to be $8.10 to $8.45 for the full year 2025[49] Tariff Impact - The total annualized tariff impact is estimated to be approximately $100 million[54]

Financial Data and Key Metrics Changes - First quarter sales reached $848 million, with core growth of 1.4%, slightly better than initial guidance [11][5] - Adjusted EBITDA was $187 million, representing a margin of 22.1%, a decrease of 60 basis points year-over-year [13] - Gross margin expanded to 40.7%, exceeding the 40% threshold for the fourth consecutive quarter [13] - Adjusted earnings per share increased by approximately 6% to $0.36 [14] - Free cash flow for the first quarter was an outflow of $19 million, consistent with normal seasonal performance [23] Business Line Data and Key Metrics Changes - In the Power Transmission segment, revenues were $527 million, translating to a core increase of approximately 2% [14] - Automotive replacement channel sales grew mid single digits, while industrial OEM sales experienced a slight decline [15] - Fluid Power segment sales were $320 million, with core sales approximately flat [15][16] - Personal mobility saw over 30% growth, contributing positively to overall performance [12] Market Data and Key Metrics Changes - North America returned to growth with low single-digit core sales growth, driven by mid-teens growth in automotive replacement [18] - EMEA and South America both experienced year-over-year declines [18] - China core sales expanded by 3.5%, with broad-based growth in industrial end markets [20] - Personal mobility growth was robust, particularly in Europe and Asia, with no observed pre-buy activity [62] Company Strategy and Development Direction - The company is focused on mitigating tariff impacts through price increases and operational initiatives [8][26] - Management emphasized the importance of maintaining a strong balance sheet and capital deployment capacity [30] - The company is committed to advancing enterprise initiatives aimed at improving cost structures and mitigating tariff headwinds [29] Management's Comments on Operating Environment and Future Outlook - Management noted ongoing uncertainty in the market due to tariffs but expressed confidence in the team's ability to manage through economic cycles [10][29] - Customer demand in the second quarter has been consistent with initial guidance, though potential risks remain [28] - The company is prepared to implement action plans should demand soften relative to expectations [29] Other Important Information - The company repurchased $13 million of shares during the quarter, with over $100 million remaining under the existing authorization [23] - The net leverage ratio improved to 2.3 times, a slight decrease year-over-year [23] Q&A Session Summary Question: Can you discuss the tariff impact and competitive positioning? - Management expects to offset approximately 75% to 80% of the $50 million tariff impact with price increases, with the remainder offset through operational initiatives [36][38] - The company believes it has a competitive advantage due to its in-region, for-region manufacturing strategy [40] Question: What is the status of internal initiatives and their relation to current trends? - Management reported solid execution on internal initiatives, with progress ahead of schedule contributing to gross margin performance [44] Question: How is demand evolving in different end markets? - Management noted that while automotive builds are expected to decline, the automotive replacement market remains robust [56][58] - Personal mobility has shown strong growth, with no pre-buy activity observed [62] Question: What is the company's approach to pricing and tariff mitigation? - Price increases are expected to be implemented in Q2, with realization impacting Q3 [116] - The company plans to manage compressible costs to protect underlying operating margins [46] Question: Can you provide an update on channel partners and inventory? - Management indicated that channel partners have not shown significant changes in buying behavior, maintaining a balance between sales in and sales out [100]

Financial Data and Key Metrics Changes - The company reported adjusted EBITDA of $30 million for Q1 2025, at the high end of guidance, driven by strong operational performance and increased production and sales volumes, primarily due to the Augusta acquisition [6][24] - Net sales increased by 46% to $378 million compared to Q1 2024, largely attributed to the Augusta acquisition [6][24] - The company incurred a consolidated net loss of approximately $6 million from continuing operations, equating to $0.36 per diluted share [23] Business Line Data and Key Metrics Changes - The Augusta mill integration has been successful, with targeted volume and cost synergies expected by the end of 2026 [7] - Fixed cost structure was reduced by eliminating over 200 positions, representing around 10% of total roles, aiming for $30 to $40 million in savings for 2025 [7][18] Market Data and Key Metrics Changes - Industry shipments increased by 2% in Q1 2025 compared to Q1 2024, with demand projected to grow by 3% to 5% in 2025 [8][9] - Industry utilization rates improved to 88% in Q1 2025 from 84% in Q1 2024, but remain below the cross-cycle average of 90% to 95% [10] Company Strategy and Development Direction - The company aims to strengthen its position as a premier independent supplier of paperboard packaging products, investing in product development across three categories: compostable food service products, lightweight folding carton products, and alternative poly-free barrier technologies [13][14][15] - The company is exploring expansion into additional paperboard substrates, which make up approximately 50% of the paperboard market outside of SBS [16] Management's Comments on Operating Environment and Future Outlook - Management remains optimistic about medium to long-term industry prospects, expecting strong margins and cash flows through the cycle [34] - The company anticipates continued demand recovery, with internal utilization projected at around 85% and revenue expectations of approximately $1.5 to $1.6 billion for 2025 [29] Other Important Information - The company repurchased approximately $11 million of its shares in Q1 2025, totaling about $15 million since the new $100 million share buyback authorization [7][26] - The company is targeting a reduction in SG&A as a percentage of sales to 6% to 7% by year-end 2025 [25] Q&A Session Summary Question: What is the sense of what's happening with FPB imports recently? - Management noted that imports were up in 2024, with forecasts for a 5% decrease in imports and a 1% increase in exports for 2025 [38][39] Question: Can you clarify the geographic split of the $20 million to $25 million purchases from outside the US and Canada? - Approximately $80 million of imports are from Canada, with the remaining $20 million from other parts of the world, including potential exposure to China [40][41] Question: What are the criteria for evaluating M&A opportunities for expanding product offerings? - The company seeks strategic fit, quality assets, and a belief in the ability to win in the market when considering M&A [46][47] Question: What kind of costs are associated with the paper machine upgrades for lightweight folding carton products? - Upgrades will be on existing machines, with capital fitting within the previously stated capital range, focusing on mix shift rather than incremental revenue growth [48] Question: What is the expected impact of cost savings in Q2? - Management expects to see roughly double the amount of savings in Q2 compared to Q1, with incremental benefits ramping through the year [51]

Financial Performance - 公司第一季度销售额为15.36亿美元，同比下降12%[9] - 调整后的每股收益为负0.90美元，同比下降1.13美元[9] - 调整后的EBITDA利润率为3.4%，同比下降291个基点[9] - 北美零售额下降7%[9] Tariff Impact and Mitigation - 预计2025年关税净新增影响为2.6亿至3亿美元[22] - 公司正在采取行动，到年底将中国采购减少30%[22] - 墨西哥对美国的进口产品中，目前约95%符合USMCA（美国-墨西哥-加拿大协议）的资格[22] - 采取关税缓解措施和延期后，预计2025年净新增关税影响将低于2.25亿美元[25] Segment Performance - 北美ORV（越野车）零售额同比下降11%[41] - Indian Motorcycle在北美市场份额有所增长，但零售额同比下降了十几个百分点[47] - Marine（船艇）业务的经销商库存同比下降约20%[54] Outlook and Strategy - 由于全球经济政策（关税）的不确定性，公司撤回了2025财年的业绩指引[12] - 公司预计第二季度销售额在16亿至18亿美元之间[61] - 公司正在实施现金储备策略，以应对市场不确定性[58]

Financial Data and Key Metrics Changes - Revenue from continuing operations grew 23.1% year over year to RMB9.39 billion, while total revenue achieved RMB9.65 billion, representing a 21% year over year growth [9] - Adjusted non-IFRS net profit grew 40% year over year to RMB2.68 billion, with a record backlog for continuing operations of RMB52.33 billion, growing 47.1% year over year [9][10] - Adjusted IFRS gross profit margin reached 41.9%, with net profit attributable to the owners of the company increasing by 89.1% year over year [26][27] Business Line Data and Key Metrics Changes - Wuxi Chemistry's CRDMO business revenue grew 32.9% year over year to RMB7.39 billion, with adjusted non-IFRS gross profit margin improving 4.2 percentage points year over year to 47.5% [11][12] - Small molecule DNM business revenue grew 13.8% year over year to RMB3.85 billion, with both Changzhou and Taishin API manufacturing sites passing FDA inspections [13] - Tides business achieved RMB2.24 billion revenue in the first quarter, representing a strong growth of 187.6% year over year [14] Market Data and Key Metrics Changes - Revenue from the U.S. market grew 28.4% year over year, while revenue from Europe grew 26.2% year over year; however, China showed a slight decline [10] - Revenue generated from clinical CRO and SMO business was down 2.2% year over year to RMB0.61 billion, attributed to market price impact [21][22] Company Strategy and Development Direction - The company will continue to focus on the CRDMO business model with an emphasis on operational efficiency and exceptional services [29] - Full year guidance is maintained, expecting revenue from continuing operations to resume double-digit growth of 10% to 15% year over year, targeting total revenue of RMB41.5 billion to RMB43 billion [30] - The company plans to accelerate global D and M capacity expansion, with CapEx expected to reach RMB7 billion to RMB8 billion [30] Management Comments on Operating Environment and Future Outlook - Management acknowledges the dynamic and complex global environment, emphasizing the need for operational resilience [29] - Despite external uncertainties, the company maintains confidence in its business model and operational capabilities [30] - The management team is committed to enhancing shareholder value through dividends and share repurchase plans [31][32] Other Important Information - The company plans to maintain a 30% annual cash dividend payout ratio of net profit, totaling approximately RMB2.8 billion, along with a one-time special cash dividend of RMB1 billion [31] - The company will repurchase and cancel RMB1 billion worth of A shares when appropriate in 2025 [32] Q&A Session Summary Question: What are the key drivers behind the robust growth in Tides? - The growth is attributed to both strong demand and capacity ramping up from a low base last year [37] Question: How does the company view the impact of tariffs on business segments? - Tariffs are seen as a systemic challenge, with less than 10% of total revenue coming from exports to the U.S. [45][46] Question: What is the expected CapEx distribution for 2025? - CapEx will focus on expanding new modality and small molecule capacities in China, Singapore, and the U.S., with over 70% allocated to D and M manufacturing capacity expansion [54] Question: How does the company plan to address pricing pressures in testing and biology segments? - The company aims to focus on contracts with higher margins and differentiation strategies to improve margins gradually [68] Question: What is the expected revenue contribution from late-stage D and M projects? - Specific numbers are difficult to provide, but the company expects sustained growth from its CRDMO business model [71]

Investment Rating - The report does not explicitly provide an investment rating for the sectors discussed Core Insights - The report highlights the impact of increased US tariffs on various sectors including appliances, autos, industrial tech, and solar companies, with management expressing concerns over supply chain disruptions and capital allocation strategies China Consumer Durables - Companies derive an average of 35% of revenues from China exports and 7% from exports to the US [5] - Production is shifting to overseas factories, with some companies receiving more orders from US clients as they seek to restock before the tariff reprieve period ends [6] - There is low visibility on price re-negotiation, with companies cautious about raising prices due to market share concerns [6] - Ex-US demand remains stable, particularly in Europe, which is expected to absorb US capacity [6] - CAPEX visibility is low, with Mexico considered a safer investment location due to its free trade agreement with the US [6] China Autos - Companies derive 6%-26% of total revenue from China exports and 0%-10% from exports to the US [7] - Management believes US-China trade tensions have softened recently, with expectations of higher exports to Europe due to ongoing negotiations [7] - Auto suppliers report no order cancellations and are negotiating new prices, with some passing on the full tariff burden to customers [8][10] China Industrial Tech - Companies derive 15%-45% of total revenue from exports and 2%-20% from exports to the US [11] - Orders paused initially in early April but returned to normal by the second week, with some customers continuing their overseas construction plans despite tariff uncertainties [11] - Most companies have signed FOB contracts, meaning customers bear the tariff costs [11] - Companies are maintaining existing capacity expansion plans, with some pausing expansion until tariff policies are clearer [12] China Solar - Companies involved in solar exports have 0%-15% direct exports to the US and 35%-55% to other countries [17][18] - One company has stopped shipping ESS products to the US due to high tariffs, while others are expanding inverter capacity overseas [19] - Softening demand in the US is a key challenge, with concerns over potential price hikes dampening downstream demand [20] - Companies are considering scaling back US exposure if operational risks outweigh profitability compared to other regions [20]

Core Viewpoint - Lumibird Group reported a consolidated revenue growth of 12.4% in Q1 2025, reaching €49.4 million, driven by strong performance in both the Photonics and Medical divisions [1][3]. Revenue Summary - Consolidated revenues for Q1 2025 were €49.4 million, an increase of 12.4% compared to €43.9 million in Q1 2024, with a constant exchange rate growth of 11.7% [3]. - The Photonics division generated €23.9 million, up 15.8% from €20.6 million in Q1 2024, with a constant exchange rate growth of 15.1% [3][4]. - The Medical division achieved revenues of €25.5 million, reflecting a growth of 9.4% from €23.3 million in Q1 2024, with a constant exchange rate growth of 8.6% [3][6]. Division Performance - The Defence/Space business within the Photonics division saw sales rise by 37.8% to €10.5 million, attributed to multi-year contracts and order book deliveries [4]. - Industrial and Scientific sales increased by 7.0% to €5.9 million, including €0.5 million from the Continuum range acquired in October 2024 [5]. - Medtech sales slightly declined by 2.3% to €3.9 million, impacted by the timing of deliveries throughout 2025 [5]. Geographical Breakdown - EMEA revenues for Photonics were €13.8 million, up 16.2%, while Medical revenues were €7.6 million, down 6.0% [7]. - In the Americas, Photonics revenues increased by 54.1% to €4.5 million, and Medical revenues rose by 2.1% to €6.6 million [7]. - Asia-Pacific Photonics revenues decreased by 17.5% to €2.9 million, while Medical revenues increased by 29.1% to €8.1 million [7]. Future Outlook - Lumibird anticipates continued business expansion driven by growth in Defence/Space and Medical markets, with no significant impact expected from increased customs barriers [10][11].

Financial Data and Key Metrics Changes - InMode generated total revenue of $77.9 million in Q1 2025, a decrease of 3% compared to Q1 2024 [8] - GAAP gross margin was 78% in Q1 2025, down from 80% in Q1 2024 [8] - Non-GAAP diluted earnings per share were $0.31, compared to $0.32 in Q1 2024 [12] - The company ended the quarter with cash and cash equivalents of $512.9 million [12] Business Line Data and Key Metrics Changes - Minimally invasive platforms accounted for 87% of total revenues in Q1 2025 [9] - Sales and marketing expenses decreased slightly to $39.7 million in Q1 2025 from $39.8 million in Q1 2024 [11] Market Data and Key Metrics Changes - International sales accounted for $38 million or 49% of total sales, a 1% increase compared to Q1 2024 [9] - Europe was the largest revenue contributor from outside the U.S., achieving record sales [10] Company Strategy and Development Direction - The company plans to unveil a new platform for the wellness market later this year, reflecting its strategy to diversify offerings [6] - InMode has committed to not reducing its workforce and aims to lead the industry during the market rebound [6] Management's Comments on Operating Environment and Future Outlook - Management noted ongoing macroeconomic uncertainty and soft consumer demand affecting the medical aesthetic market [4] - The company anticipates a potential reduction in operating margins by 4% to 5% due to market pressures and U.S. tariffs [13] - Management remains optimistic about a market recovery, contingent on Q2 performance [30] Other Important Information - InMode returned over $412 million to shareholders through share repurchases over the past twelve months, representing approximately 27% of total capital [7] - The company has not yet hired a new President for the U.S. and is currently led by the acting President [66] Q&A Session Summary Question: Follow-up on product mix dynamics - Management indicated that the slowdown began in mid-2023 due to rising interest rates and decreased consumer confidence, impacting capital equipment purchases [20][21] Question: Guidance for Q2 and market trends - Management expects Q2 to be stronger than Q1, but if results do not improve, guidance may need to be lowered [31][40] Question: Impact of tariffs on guidance - Tariffs are expected to impact gross margins by approximately 2% to 3% if they remain at 10% [57][79] Question: Updates on operating expenses - The company plans to maintain its investment in sales and marketing despite macro challenges, which may impact profitability [65] Question: Pricing strategy in the current market - Management decided not to raise prices due to the current market conditions, despite tariff impacts [70][90] Question: Performance in Europe compared to the U.S. - Europe has shown better performance due to management changes and pricing strategies, although credit conditions are tightening [83]

Investment Rating - The industry view is rated as Attractive, with a preference for gold, cement, building materials, and steel for 2Q25 [7]. Core Insights - Demand in the materials sector showed signs of recovery in 1Q25, but the outlook for 2Q25 is uncertain due to tariff concerns. Domestic excavator sales increased by 38% YoY, and orders from cathode producers rose by 20% due to strong demand from electric vehicles (EV) and energy storage [2]. - The report anticipates that metals-related stocks may outperform in 2H25 as further stimulus is expected [1][6]. - The tariff impact is projected to weigh heavily on the materials space, with a forecasted GDP growth reduction of 30 basis points to 4.2% for 2025 due to tariff shocks and domestic demand impacts [2][18]. Summary by Sections Gold - Gold is identified as the top pick within commodities, supported by ongoing central bank buying and rising ETF inflows. Lower Treasury yields are expected to enhance gold's macro backdrop. Preferred stocks include Zhaojin (1818.HK) and Zijin Mining (2899.HK, 601899.SS) [3]. Cement and Steel - Cement supply-side controls were announced in November 2024, leading to a focus on profitability rather than price wars. The report expects a significant increase in gross profit per ton due to lower coal prices and higher cement prices. For steel, a production cut of 30 million tons and an export cut of 15-20 million tons are anticipated in 2025. Preferred stocks include Anhui Conch (0914.HK, 600585.SS), CNBM (3323.HK), and Baosteel (600019.SS) [4]. Copper and Aluminum - In 2H25, copper and aluminum are expected to outperform due to continued demand from grid and EV-related green infrastructure. Additional fiscal stimulus could further support demand. Preferred stocks include Zijin (2899.HK, 601899.SS), CMOC (3993.HK, 603993.SS), and Hongqiao (1378.HK) [5]. Tariff Impact - The report highlights that the current cumulative US tariffs could have a more significant growth drag than in 2018-19, with expectations of trade talks to lower tariffs to 34% by year-end. The tariff shocks are expected to impact both trade channels and domestic demand [17][18].